The Clorox Company $CLX Shares Bought by Focus Partners Advisor Solutions LLC

Key Points

• Focus Partners Advisor Solutions LLC increased its stake in The Clorox Company by 66.4%, acquiring an additional 3,586 shares, bringing its total holdings to 8,984 shares valued at approximately $1.32 million.
• Several institutional investors have also recently expanded their investments in Clorox, with hedge funds now holding 78.53% of the company's stock.
• The Clorox Company reported earnings per share of $2.87 for the last quarter, exceeding projections, while announcing a dividend increase to $1.24, reflecting a 4.1% yield.

Focus Partners Advisor Solutions LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 66.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,984 shares of the company's stock after purchasing an additional 3,586 shares during the quarter. Focus Partners Advisor Solutions LLC's holdings in Clorox were worth $1,323,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after purchasing an additional 65,924 shares during the period. Northern Trust Corp raised its holdings in shares of Clorox by 2.3% in the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock valued at $225,133,000 after buying an additional 34,655 shares during the period. Invesco Ltd. raised its holdings in shares of Clorox by 7.4% in the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock valued at $200,512,000 after buying an additional 94,371 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Clorox by 12.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock valued at $181,213,000 after buying an additional 123,200 shares during the period. Finally, Hsbc Holdings PLC raised its holdings in shares of Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock valued at $159,699,000 after buying an additional 589,544 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CLX shares. UBS Group cut their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Citigroup reiterated a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Barclays cut their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. JPMorgan Chase & Co. decreased their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, Jefferies Financial Group cut their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, Clorox has a consensus rating of "Reduce" and a consensus price target of $142.64.

Clorox Stock Up 2.0%

Shares of CLX traded up $2.45 during mid-day trading on Friday, reaching $127.08. The company's stock had a trading volume of 3,231,696 shares, compared to its average volume of 1,756,627. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The stock has a market cap of $15.54 billion, a PE ratio of 19.49, a price-to-earnings-growth ratio of 1.02 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company's 50 day moving average is $124.17 and its 200 day moving average is $133.35.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the prior year, the business posted $1.82 EPS. The business's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were paid a dividend of $1.24 per share. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 3.9%. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio (DPR) is 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.